The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients
Article
[키워드] antibodies
antibody
Antibody Response
B cell
B cell response
B cells
B-cell
B-cell response
binding activity
Blood
booster dose
Cell
collected
COVID-19
dose
dose administration
elicited
ENhance
Frequency
healthy controls
humoral
immune response
immune responsiveness
Immunosuppressive treatment
in vitro
increase
Interaction
JAK inhibitor
memory B
memory B-cell
Moderna
mononuclear cell
mRNA
mRNA SARS-CoV-2 vaccination
mRNA vaccine
mRNA-1273
mRNA-based vaccine
myelofibrosis
Patient
patients
Peripheral blood
positive
remained
responders
ruxolitinib
SARS-CoV-2
SARS-CoV-2 BNT162b2
SARS-CoV-2 vaccination
SARS-CoV-2 vaccine
second vaccination
significant increase
significantly increased
Spike-specific antibody
spike-specific IgG
subject
subjects
tested
the SARS-CoV-2
therapy
third booster dose.
treated
untreated patients
vaccination
vaccine dose
Vaccines
was measured
while
[DOI] 10.3389/fimmu.2022.1017863 PMC 바로가기
[DOI] 10.3389/fimmu.2022.1017863 PMC 바로가기